These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 16553220)

  • 1. [Biochips--tools of 21st century medicine].
    Bürger J
    Versicherungsmedizin; 2006 Mar; 58(1):9-13. PubMed ID: 16553220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Applications of biochips: from diagnostics to personalized medicine.
    Jain KK
    Curr Opin Drug Discov Devel; 2004 May; 7(3):285-9. PubMed ID: 15216931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of Proteomics in the Development of Personalized Medicine.
    Jain KK
    Adv Protein Chem Struct Biol; 2016; 102():41-52. PubMed ID: 26827601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Personalized oncology: recent advances and future challenges.
    Kalia M
    Metabolism; 2013 Jan; 62 Suppl 1():S11-4. PubMed ID: 22999010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prenatal genetic care: debates and considerations of the past, present and future.
    Faas BH
    Expert Opin Biol Ther; 2015; 15(8):1101-5. PubMed ID: 25959656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The current status and future potential of personalized diagnostics: Streamlining a customized process.
    Richmond TD
    Biotechnol Annu Rev; 2008; 14():411-22. PubMed ID: 18606372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Current status and the future of insurance medicine].
    Sittaro NA
    Versicherungsmedizin; 2002 Sep; 54(3):111-21. PubMed ID: 12242772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Predictive genetic testing for hereditary breast cancer and hereditary nonpolyposis colorectal cancer].
    Heyll U; Slany E
    Versicherungsmedizin; 2007 Sep; 59(3):129-35. PubMed ID: 17912887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comment on N.-A. Sittaro: Current status and future of insurance medicine].
    Hakimi R
    Versicherungsmedizin; 2003 Mar; 55(1):45-6; author reply 47. PubMed ID: 12652933
    [No Abstract]   [Full Text] [Related]  

  • 10. [International developmental trends in life insurance medicine 1971-1995].
    Kraus HK
    Versicherungsmedizin; 1996 Apr; 48(2):36-9. PubMed ID: 8659049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging trends in genetic-based medical diagnostics.
    Robinson K
    Clin Leadersh Manag Rev; 2005 May; 19(3):E2. PubMed ID: 15927094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Genome analysis - what does the future hold, what is science fiction? Interview by Prof. Dr. med. Johann Steurer].
    Hafen E; Roose A
    Praxis (Bern 1994); 2012 Jul; 101(15):971-4. PubMed ID: 22811330
    [No Abstract]   [Full Text] [Related]  

  • 13. Applications of microarrays and biochips in pharmacogenomics.
    Hardiman G
    Methods Mol Biol; 2008; 448():21-30. PubMed ID: 18370228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic testing for breast and ovarian cancer: implications for life insurance.
    Lemaire J; Subramanian K; Asch DA
    LDI Issue Brief; 2000 Mar; 5(6):1-4. PubMed ID: 12523344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Current status and perspectives for genetic consultation and prophylactic medical examination of risk groups with malignant neoplasms of the female reproductive system and breast].
    Akulenko LV; Gar'kavtseva RF; Zhordania KI; Samgina AA
    Tsitol Genet; 1992; 26(1):38-42. PubMed ID: 1621284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmacogenomics: hype or hope?].
    Schwab M; Schaeffeler E; Zanger UM; Brauch H; Kroemer HK
    Dtsch Med Wochenschr; 2011 Mar; 136(10):461-7. PubMed ID: 21365522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Legal rules and industry norms: the impact of laws restricting health insurers' use of genetic information.
    Hall MA
    Jurimetrics; 1999; 40(1):93-122. PubMed ID: 12737178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Confidentiality and genetic test results.
    Meletzke O
    J Insur Med; 1993; Suppl B():279-86. PubMed ID: 10146363
    [No Abstract]   [Full Text] [Related]  

  • 20. Biochip technologies in cancer research.
    Kallioniemi OP
    Ann Med; 2001 Mar; 33(2):142-7. PubMed ID: 11327117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.